By Manas Mishra
The unit, CCRE, offered $110 in cash for each share of China Biologic it does not already own.
Bintang Capital will focus on mid-sized companies based in the Asia Pacific.
Combining with its Fund II, Delta Capital’s total assets under management has reached close to $120 million.
33 investors from Asia have allotted over $1B to PE in 2018.
In a recent deal, India Resurgent Fund (IRF), a JV between Piramal Enterprises and Bain Capital Credit, invested Rs 800 crore in Archean Chemical Industries Ltd, buying out its lenders
This is SeaLink’s second deal from debut fund after NephroPlus Health in August 2016.
In 2015, the Hyderabad-based solar energy company had raised $2 million from clean tech fund, Infuse Ventures and others.
GSIS has committed to invest $314 million in Philippine Investment Alliance for Infrastructure (Pinai) fund,
The deal values the South Korean games maker Bluehole at over $5 billion.
DDH1 continues to seek acquisition opportunities in the drilling space.